RadiSys Corporation (NASDAQ:RSYS) last session’s volume of 16.59 million shares was higher than its average volume of 0.46 million shares. The stock, after opening at $0.8789, hit $0.93 through the close by scoring 5.17%.

RadiSys Corporation (RSYS) Analyst Opinion

RadiSys Corporation has a consensus outperform rating from 5 Wall Street analysts, and the number of shares currently sold short amount to at least 2.36% of shares outstanding. The stock sank -32.61% last month and is down -79.01 this year. Wall Street is only getting more bullish on the stock, with 5 of analysts who cover RSYS having a buy-equivalent rating. Analysts have placed a $2.55 price target on RadiSys Corporation, suggesting a 174.19% gain from recent close. It’s currently trading about -82.32% below its 52-week high.

RadiSys Corporation Earnings Surprise

RadiSys Corporation (RSYS) failed to surprise the stock market in its last reported earnings when it earned -$0.28 a piece versus the consensus-estimated -$0.14. Its revenue totaled $28.11 million down -19.89% from the previous quarter.

RadiSys Corporation (NASDAQ:RSYS) Intraday View

This stock (RSYS) is ahead of its 52-week low with 48.59%. Its last month’s stock price volatility remained 19.88% which for the week stands at 16.33%. The share price has moved forward from its 20 days moving average, trading at a distance of 13.22% and stays -17.84% away from its 50 days moving average. Over the last five days, shares have managed 22.37% gains and now is down -64.7% since hitting its 200-day moving average of $2.06. RadiSys Corporation (RSYS) has made its way to a 12-month decline of -79.19%.

Turning to Corindus Vascular Robotics, Inc. (NYSE:CVRS), its shares were trading at $1.13 a retreat of $-0.14, on the trading floor. The stock, after opening at $1.27, touched a high of $1.28 before paring much of its gains. So far, analysts are sticking with their bullish recommendations with the consensus call at 1.5. Corindus Vascular Robotics, Inc. has 1 buy ratings, 0 holds and 0 sells even after the stock tumbled -49.78% from its high of $2.25 to a $208.3 million market value through last close.

Corindus Vascular Robotics, Inc. (CVRS) Consensus Price Target

The company’s consensus rating on Reuter’s scale remained unchanged from 1.5 to 1.5 during a month. Analysts set a 12-month price target of $2.38 a share. The target implies a 110.62% spike from where the shares are currently trading. Also, the current price highlights a discount of 165.49% to analysts’ high consensus price target.

Corindus Vascular Robotics, Inc. (NYSE:CVRS) Intraday Trading

The counter witnessed a trading volume of 0.6 million shares versus an average volume of 0.79 million shares during last trading session. Its last month’s stock price volatility remained 15.62% which for the week approaches 18.7%. The lowest price the stock reached in the last trading day was $1.12 and compares with the $0.40 52-week low. The stock recovered 181.3% since its low point and has performed 61.8% year-to-date.